Irina Yu. Adamova

Irina Yu. Adamova

Auto-generated profile, based on publicly available information

Irina Yu. Adamova

Laboratory of Atherosclerosis, Institute of Experimental Cardiology, Federal State Institution "Russian Cardiology Research and Production Center" of Ministry of Health of the Russian Federation, 15A, 3d Cherepkovskaya Street, Moscow 121552, Russia

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Atherosclerosis Supplements
Verified
Journal Article
Closed access
MSMaya S. Safarova
Maya S. Safarova
MEMarat V. Ezhov
Marat V. Ezhov
OAOlga Afanasieva
Olga Afanasieva
YMYuriy G. Matchin
Yuriy G. Matchin
RARuslan V. Atanesyan
Ruslan V. Atanesyan
SPSergei N. Pokrovsky
Sergei N. Pokrovsky

1 April 1991 in Artificial Organs
Verified
Journal Article
Closed access
PDF file
SPSergei N. Pokrovsky
Sergei N. Pokrovsky
IAIrina Yu. Adamova
Irina Yu. Adamova
OAOlga Afanasieva
Olga Afanasieva

1 January 1994 in Chemistry and Physics of Lipids
Verified
Journal Article
Closed access
SPSergei N. Pokrovsky
Sergei N. Pokrovsky
ASAndrei V. Sussekov
Andrei V. Sussekov
OAOlga Afanasieva
Olga Afanasieva
IAIrina Y. Adamova
Irina Y. Adamova
ALAnatoly A. Lyakishev
Anatoly A. Lyakishev
VKValery V. Kukharchuk
Valery V. Kukharchuk

1 November 2017 in Atherosclerosis Supplements
Verified
Journal Article
Closed access
SPSergei N. Pokrovsky
Sergei N. Pokrovsky
OAOlga Afanasieva
Olga Afanasieva
MSM.S. Safarova
M.S. Safarova
TBT.V. Balakhonova
T.V. Balakhonova
YMYu.G. Matchin
Yu.G. Matchin
MEM.V. Ezhov
M.V. Ezhov

1 May 2015 in Atherosclerosis Supplements
Verified
Journal Article
Closed access
Marat EzhovMarat Ezhov
Marat Ezhov
MSM.S. Safarova
M.S. Safarova
OAOlga Afanasieva
Olga Afanasieva
OPO.A. Pogorelova
O.A. Pogorelova
MTM.I. Tripoten
M.I. Tripoten
SPSergei N. Pokrovsky
Sergei N. Pokrovsky

12 January 2019 in FEBS Open Bio
Verified
Journal Article
Open access
PDF file
Pavel A LevashovPavel A Levashov
Pavel A Levashov
DMDarya A. Matolygina
Darya A. Matolygina
EOEkaterina D. Ovchinnikova
Ekaterina D. Ovchinnikova
IAIrina Yu. Adamova
Irina Yu. Adamova
DGDarya A. Gasanova
Darya A. Gasanova
ALAndrey V. Levashov
Andrey V. Levashov
The emergence of new antibiotic‐resistant bacterial strains means it is increasingly important to find alternatives to traditional antibiotics, such as bacteriolytic enzymes. The bacteriolytic enzyme lysozyme is widely used in medicine as an antimicrobial agent, and covalent immobilization of lysozyme can expand its range of possible applications. However, information on the effect of such immobilized preparations on whole bacterial cells is quite limited. Here, we demonstrate the differential effects of glycine and charged (basic and acidic) amino acids on the enzymatic lysis of Gram‐positive and Gram‐negative bacteria by soluble and immobilized lysozyme. Glycine and basic amino acids (histidine, lysine, and arginine) significantly increase the rate of lysis of Gram‐negative Escherichia coli cells in the presence of soluble lysozyme, but they do not substantially affect the rate of enzymatic lysis of Gram‐positive Micrococcus luteus. Glutamate and aspartate significantly enhance enzymatic lysis of both E. coli and M. luteus. When using immobilized lysozyme, the effects of amino acids on the rate of cell lysis are significantly reduced. For immobilized lysozyme, the presence of an external diffusion mode on cell lysis kinetics at bacterial concentrations below 4 × 108 colony‐forming units·mL−1 was shown. The broadening of the pH optimum of lysozyme activity after immobilization has been demonstrated for both Gram‐positive and Gram‐negative bacteria. The Michaelis constant (Km) values of immobilized lysozyme were increased by 1.5‐fold for E. coli cell lysis and 4.6‐fold for M. luteus cell lysis compared to soluble enzyme. A greater understanding of the effect of amino acids on the activity of native and immobilized lysozyme is important for both the development of new materials for medical purposes and elucidating the interaction of lysozyme with bacterial cells. Of particular interest is our finding that lysozyme activity against Gram‐negative bacteria is enhanced in the presence of glycine and charged amino acids over a wide range of concentrations.